Europe — EMA
Oxervate (Cenegermin)
Cenegermin, the active ingredient in Oxervate, is a neurotrophic factor presented as a ophthalmic solution for topical ocular use. It treats neurotrophic keratitis in patients with damaged corneal innervation.
Request sourcing
What is Cenegermin?
Cenegermin, the active ingredient in Oxervate, is a neurotrophic factor presented as a ophthalmic solution for topical ocular use. It treats neurotrophic keratitis in patients with damaged corneal innervation. GNH USA supplies Oxervate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.
GNH USA supplies Oxervate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.
What is Cenegermin used for?
Oxervate is a recombinant human nerve growth factor indicated for conditions affecting corneal surface health.
- Neurotrophic keratitis: promotes healing of the corneal epithelium and reduces ulceration risk. - Persistent epithelial defect: supports re‑epithelialisation of corneal lesions unresponsive to conventional therapy. - Post‑surgical corneal nerve injury: aids recovery of corneal sensitivity and epithelial integrity after ocular surgery.
What are the side effects of Cenegermin?
Oxervate may present the following adverse reactions.
Common Side Effects: - Eye irritation : burning sensation of the eye at instillation or temporary red eye. - Conjunctival hyperemia : red t of the conjunct . - Foreign‑body feel : situs of a s s . - Tearing : increased lacrimal production . - Photophobia : light sensitivity . - Headache : mild head ache .
Serious or Rare : - Cor oot oot oot oot oot oot bsp oot oot ... - ... - ...
What precautions apply to Cenegermin?
Oxervate e … ewline \
